Eizo Kimura
- Reproductive Medicine top 1%
- Ovarian cancer diagnosis and treatment 10
- Obstetrics and Gynecology top 2%
- Oncology top 10%
- Cancer Treatment and Pharmacology 3
- Surgery top 10%
- Nausea and vomiting management 3
- Intraperitoneal and Appendiceal Malignancies 3
-
- Chemotherapy-induced organ toxicity mitigation 2
-
- Renal cell carcinoma treatment 6
-
- Pathogenesis and Treatment of Hiccups 3
-
- Heat shock proteins research 3
Eizo Kimura
18 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Reproductive Medicine 754
- Obstetrics and Gynecology 290
- Oncology 370
- Surgery 394
- Pathology and Forensic Medicine 109
Countries citing papers authored by Eizo Kimura
This map shows the geographic impact of Eizo Kimura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eizo Kimura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eizo Kimura more than expected).
Fields of papers citing papers by Eizo Kimura
This network shows the impact of papers produced by Eizo Kimura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eizo Kimura. The network helps show where Eizo Kimura may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eizo Kimura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2020 | 5 | |
| 3 | 2019 | 1 | |
| 4 | 2019 | 9 | |
| 5 | 2015 | 15 | |
| 6 | 2015 | 1 | |
| 7 | 2014 | 43 | |
| 8 | 2014 | 1 | |
| 9 | Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trialbreakdown → | 2013 | 331 |
| 10 | 2012 | 21 | |
| 11 | Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trialbreakdown → | 2009 | 502 |
| 12 | 2008 | 4 | |
| 13 | 2008 | 25 | |
| 14 | [Dose finding study of paclitaxel and carboplatin for ovarian cancer (JKTB)]. | 2001 | 3 |
| 15 | [Clinical effect of two azasetron treatment methods against nausea and vomiting induced by anticancer drugs including CDDP]. | 1997 | 3 |
| 16 | [Study on clinical effect of a continuous intravenous infusion of azasetron against nausea and vomiting induced by anticancer drugs including CDDP]. | 1996 | 18 |
| 17 | 1993 | 53 | |
| 18 | 1993 | 11 | |
| 19 | 1993 | 27 | |
| 20 | 1990 | 11 |
About Eizo Kimura
Eizo Kimura is a scholar working on Reproductive Medicine, Oncology, Physical and Theoretical Chemistry, Pulmonary and Respiratory Medicine and Surgery, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (10 papers), Renal cell carcinoma treatment (6 papers), Nausea and vomiting management (3 papers), Intraperitoneal and Appendiceal Malignancies (3 papers), Cancer Treatment and Pharmacology (3 papers), Pathogenesis and Treatment of Hiccups (3 papers), Heat shock proteins research (3 papers) and Chemotherapy-induced organ toxicity mitigation (2 papers). The work is most often cited by research in Reproductive Medicine (754 citations), Obstetrics and Gynecology (290 citations), Oncology (370 citations), Surgery (394 citations) and Pathology and Forensic Medicine (109 citations). Eizo Kimura has collaborated with scholars based in Japan and United States. Frequent co-authors include Toru Sugiyama, Kazunori Ochiai, Seiji Isonishi, Toshiko Jobo, Makoto Yasuda, Daisuke Aoki, Fumiaki Takahashi, Noriyuki Katsumata, Shoji Kodama and Hiroshi Tsuda. Their work appears in journals such as Journal of Clinical Oncology, Human Cell, Cancer Chemotherapy and Pharmacology, Journal of Gynecologic Oncology and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.